Proto Labs Q1 2024 Adj EPS $0.40 Beats $0.31 Estimate, Sales $127.890M Beat $124.683M Estimate
Portfolio Pulse from Benzinga Newsdesk
Proto Labs (NYSE:PRLB) reported Q1 2024 adjusted EPS of $0.40, surpassing the $0.31 estimate, and sales of $127.890M, exceeding the $124.683M estimate. This represents a 33.33% increase in EPS and a 1.61% increase in sales from the same period last year.
May 03, 2024 | 10:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Proto Labs reported a significant beat on both EPS and sales estimates for Q1 2024, indicating strong financial performance and potential growth.
The significant beat on both EPS and sales estimates for Q1 2024 by Proto Labs suggests a strong financial performance and operational efficiency, likely leading to positive investor sentiment and potential stock price appreciation in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100